middle.news
Cleo Diagnostics Clarifies Share Surge Amid Ovarian Cancer Tech Progress
9:30am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Cleo Diagnostics Clarifies Share Surge Amid Ovarian Cancer Tech Progress
9:30am on Monday 2nd of June, 2025 AEST
Key Points
Share price rose from $0.35 to $0.44 with increased trading volume
No undisclosed material information explaining price movement
Patented ovarian cancer detection technology with 95% sensitivity and specificity
Ongoing U.S. clinical trials aiming for FDA submission in 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE